Tegaserod: withdrawal from the world market. A treatment for constipation with cardiovascular adverse effects

Prescrire Int. 2008 Jun;17(95):112-3.
No abstract available

MeSH terms

  • Cardiovascular Diseases / chemically induced*
  • Constipation / drug therapy
  • Drug Approval
  • Drug-Related Side Effects and Adverse Reactions
  • Health Care Sector
  • Humans
  • Indoles / adverse effects*
  • Indoles / therapeutic use

Substances

  • Indoles